• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PD-1:T 细胞耗竭的驱动者还是乘客?

PD-1: A Driver or Passenger of T Cell Exhaustion?

机构信息

State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.

State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.

出版信息

Mol Cell. 2020 Mar 5;77(5):930-931. doi: 10.1016/j.molcel.2020.02.013.

DOI:10.1016/j.molcel.2020.02.013
PMID:32142689
Abstract

Okazaki and colleagues report that PD-1 signaling mainly restrains effector function at the early stage of T cell activation. The authors find that cytokine genes require strong antigen stimulation and are more susceptible to PD-1 inhibition.

摘要

冈崎等人报告称,PD-1 信号主要在 T 细胞激活的早期抑制效应功能。作者发现细胞因子基因需要强烈的抗原刺激,并且更容易受到 PD-1 抑制的影响。

相似文献

1
PD-1: A Driver or Passenger of T Cell Exhaustion?PD-1:T 细胞耗竭的驱动者还是乘客?
Mol Cell. 2020 Mar 5;77(5):930-931. doi: 10.1016/j.molcel.2020.02.013.
2
PD-1 and autoimmunity.程序性死亡受体1(PD-1)与自身免疫
Crit Rev Immunol. 2011;31(4):265-95. doi: 10.1615/critrevimmunol.v31.i4.10.
3
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.程序性死亡(PD)-1:PD-配体1/PD-配体2通路在人类结核病期间抑制T细胞效应功能。
J Immunol. 2008 Jul 1;181(1):116-25. doi: 10.4049/jimmunol.181.1.116.
4
Elevated T cell activation score is associated with improved survival of breast cancer.T细胞活化评分升高与乳腺癌患者生存率提高相关。
Breast Cancer Res Treat. 2017 Aug;164(3):689-696. doi: 10.1007/s10549-017-4281-x. Epub 2017 May 9.
5
T cell checkpoint regulators in the heart.心脏中的 T 细胞检查点调节剂。
Cardiovasc Res. 2019 Apr 15;115(5):869-877. doi: 10.1093/cvr/cvz025.
6
Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells.用质粒 DNA 进行核转染以实现 CRISPR/Cas9 介导的 CD133 特异性嵌合抗原受体 T 细胞中程序性细胞死亡蛋白 1 的失活
Hum Gene Ther. 2019 Apr;30(4):446-458. doi: 10.1089/hum.2017.234. Epub 2018 Apr 27.
7
PD-1 efficiently inhibits T cell activation even in the presence of co-stimulation through CD27 and GITR.PD-1 通过 CD27 和 GITR 有效抑制 T 细胞的激活,即使在共刺激存在的情况下也是如此。
Biochem Biophys Res Commun. 2019 Apr 9;511(3):491-497. doi: 10.1016/j.bbrc.2019.02.004. Epub 2019 Feb 14.
8
Role of PD-1 during effector CD8 T cell differentiation.PD-1 在效应性 CD8 T 细胞分化中的作用。
Proc Natl Acad Sci U S A. 2018 May 1;115(18):4749-4754. doi: 10.1073/pnas.1718217115. Epub 2018 Apr 13.
9
Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells.程序性细胞死亡蛋白 1 激活优先抑制 CD28.CAR-T 细胞。
Cytotherapy. 2018 Oct;20(10):1259-1266. doi: 10.1016/j.jcyt.2018.07.005. Epub 2018 Oct 9.
10
PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.PD-1/PD-L1信号通路参与慢性丙型肝炎病毒感染中丙型肝炎病毒F蛋白诱导的T细胞功能障碍。
Immunol Res. 2016 Apr;64(2):412-23. doi: 10.1007/s12026-015-8680-y.

引用本文的文献

1
PD-1 Bispecific Killer Engager (PD-1 BiKE) effectively depletes effector T lymphocytes in experimental autoimmune encephalomyelitis.程序性死亡蛋白1双特异性杀伤衔接分子(PD-1双特异性衔接分子,PD-1 BiKE)可有效耗竭实验性自身免疫性脑脊髓炎中的效应性T淋巴细胞。
Front Immunol. 2025 Aug 13;16:1644903. doi: 10.3389/fimmu.2025.1644903. eCollection 2025.
2
Sustained Lung Inflammation Post-SARS-CoV-2 Infection in Mice Is Associated with Increased Pulmonary T Cells.新冠病毒感染后小鼠肺部的持续炎症与肺内T细胞增多有关。
Eur J Immunol. 2025 Aug;55(8):e70043. doi: 10.1002/eji.70043.
3
Upregulation of PD-1 on Peripheral T cells Subsets is Associated with Parkinson's Disease.
外周血T细胞亚群上PD-1的上调与帕金森病相关。
Mol Neurobiol. 2025 Jun 19. doi: 10.1007/s12035-025-05153-4.
4
Tumor-Associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers.肿瘤相关自然杀伤细胞调节癌症中不同的CD8 + T细胞分化程序,并有助于抵抗免疫检查点阻断剂。
Cancer Discov. 2025 Jun 18:OF1-OF23. doi: 10.1158/2159-8290.CD-24-1232.
5
T-cell activation and senescence in asymptomatic HIV/Leishmania infantum co-infection.无症状HIV/婴儿利什曼原虫合并感染中的T细胞活化与衰老
PLoS Negl Trop Dis. 2025 Mar 17;19(3):e0012848. doi: 10.1371/journal.pntd.0012848. eCollection 2025 Mar.
6
Flow cytometry immune profiling of recurrent and newly diagnosed growth hormone secreting pituitary neuroendocrine tumors: comparison of two clinical cases.复发性和新诊断的生长激素分泌型垂体神经内分泌肿瘤的流式细胞术免疫分析:两例临床病例比较
BMC Endocr Disord. 2025 Feb 12;25(1):37. doi: 10.1186/s12902-025-01865-9.
7
Immune regulatory adjuvant approach to mitigate subcutaneous immunogenicity of monoclonal antibodies.减轻单克隆抗体皮下免疫原性的免疫调节佐剂方法。
Front Immunol. 2024 Dec 10;15:1496169. doi: 10.3389/fimmu.2024.1496169. eCollection 2024.
8
A novel strategy of co-expressing CXCR5 and IL-7 enhances CAR-T cell effectiveness in osteosarcoma.共表达 CXCR5 和 IL-7 的新策略增强了 CAR-T 细胞在骨肉瘤中的疗效。
Front Immunol. 2024 Oct 10;15:1462076. doi: 10.3389/fimmu.2024.1462076. eCollection 2024.
9
A case report of the diagnosis and treatment of immune checkpoint inhibitor-related encephalitis induced by camrelizumab.卡瑞利珠单抗诱导的免疫检查点抑制剂相关脑炎的诊断与治疗病例报告
AME Case Rep. 2024 Sep 6;8:101. doi: 10.21037/acr-24-58. eCollection 2024.
10
Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment.穿越肿瘤微环境的武装嵌合抗原受体T细胞的治疗靶点。
Exp Hematol Oncol. 2024 Sep 30;13(1):96. doi: 10.1186/s40164-024-00564-w.